Regular paperPsychostimulant-like effects of p-fluoroamphetamine in the rat
References (50)
- et al.
[3H]Cocaine binding and inhibition of [3H]dopamine uptake is similar in both the rat striatum and nucleus accumbens
Eur. J. Pharmacol.
(1989) - et al.
Lowering of brain serotonin level by chloroamphetamines
Biochemical Pharmacol.
(1965) - et al.
Comparison of 4-chloro-, 4-bromo- and 4-fluoroamphetamine in rats: drug levels in brain and effects on brain serotoninserotonim metabolism
Neuropharmacology
(1975) - et al.
Reversible and irreversible phases of serotonin depletion by 4-chloroamphetamine
Eur. J. Pharmacol.
(1975) - et al.
Role of dopamine D1 and D2 receptors in mediating the d-amphetamine discriminative cue
Eur. J. Pharmacol.
(1991) - et al.
Structure-activity studies on amphetamine analogs using drug discrimination methodology
Pharmacol. Biochem. Behav.
(1984) - et al.
Role of dopamine of d-amphetamine-induced discriminative responding
Pharmacol. Biochem. Behav.
(1975) - et al.
[3H]Monoamine releasing and uptake inhibition properties of 3,4-methylenedioxymethamphetamine and p-chioroamphetamine analogues
Eur. J. Pharmacol.
(1991) - et al.
Evidence for dual serotonergic projections to neocortex: Axons from the dorsal and median raphe nuclei are differentially vulnerable to the neurotoxin p-chloroamphetamine (PCA)
Exp. Neurobiol.
(1988) - et al.
Behavioral effects of the highly selective serotonin releasing agent 5-methoxy-6-methyl-2-aminoindan
Eur. J. Pharmacol.
(1994)
5-Iodo-2-aminoindan, a nonneurotoxic analogue of p-iodoamphetamine
Pharmacol. Biochem. Behav.
(1991)
Decrease of cerebral 5-HT and 5-hydroxyindoleacetic acid by an aryl alkyl amine
Life Sci.
(1963)
p-Chloro-amphetamine releases both serotonin and dopamine into rat brain dialysates in vivo
Neurosci. Lett.
(1986)
A direct comparison between amphetamine-induced behaviours and regional brain dopamine release in the rat using intracerebral dialysis
Brain Res.
(1987)
Para-halogenated phenethylamines: similar serotonergic effects in rats by different mechanisms
Pharmacol. Biochem. Behav.
(1980)
Stereochemical effects of 3,4-methylene-dioxymethamphetamine (MDMA) and related amphetamine derivatives on inhibition of uptake of [3H]-monoamines into synaptosomes from different regions of rat brain
Biochem. Pharmacol.
(1987)
Effect of p-chloroamphetamine administration on monoamine metabolism in the rat nucleus accumbens and locomotor activity: studies with intracerebral dialysis in freely moving rats
Brain Res.
(1994)
Stimulus effects of d-amphetamine. 1: DA mechanisms
Pharmacol. Biochem. Behav.
(1992)
A neurochemical heterogeneity of the rat striatum as measured by in vivo electrochemistry and microdialysis
Brain Res.
(1990)
Structure-activity relationships in CF3 substituted phenethylamines
A drug discrimination analysis of the lysergic acid diethylamide (LSD): in vivo agonist and antagonist effects of purported 5-hydroxytryptamine antagonists and of pirenpirone, a LSD-antagonist
J. Pharmacol. Exp. Ther.
(1982)
Comparison of the discriminative stimulus properties of cocaine and amphetamine in rats
Br. J. Pharmacol.
(1977)
6-Hydroxydopamine lesions of the nucleus accumbens attenuate the discriminative stimulus effects of d-amphetamine
Drug Dev. Res.
(1989)
Structure-activity relationships among the halogenated amphetamines
Ann. NY Acad. Sci.
(1978)
Influence of ring and side substituents on the selectivity of amphetamine as a monoamine oxidase inhibitor
Res. Commun. Subst. Abuse
(1982)
Cited by (43)
Synthetic amphetamine derivatives, benzofurans, and benzodifurans
2021, Novel Psychoactive Substances: Classification, Pharmacology and ToxicologyNovel halogenated synthetic cannabinoids impair sensorimotor functions in mice
2020, NeuroToxicologyIdentification and characterization of 4-chloromethamphetamine (4-CMA) in seized ecstacy — a risk to public health
2018, Forensic Science InternationalCitation Excerpt :Based on these in vivo rat data one might expect 4-CA to have about four times the potency of MDMA. Also, in a study performed in 1995 it was demonstrated that 4-CA is a more potent 5-HT uptake inhibitor than amphetamine or 4-fluoroamphetamine, although less potent at dopamine and norepinephrine reuptake sites [17]. 4-CMA is the N-methylated derivative of 4-CA and will be more lipophilic and hence more likely to penetrate the blood–brain barrier and potentially more potent in vivo than 4-CA itself.
Effect fingerprinting of new psychoactive substances (NPS): What can we learn from in vitro data?
2018, Pharmacology and TherapeuticsRole of dopamine D1 receptor in 3-fluoromethamphetamine-induced neurotoxicity in mice
2018, Neurochemistry International
- a
Present address: Department of Pharmaceutical and Biomedical Sciences, Raabe College of Pharmacy, Ohio Northern University, Ada, OH 45810, USA.
Copyright © 1995 Published by Elsevier B.V.